BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34741959)

  • 1. CRISPR/Cas-powered nanobiosensors for diagnostics.
    Phan QA; Truong LB; Medina-Cruz D; Dincer C; Mostafavi E
    Biosens Bioelectron; 2022 Feb; 197():113732. PubMed ID: 34741959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive Biosensing.
    Fu X; Shi Y; Peng F; Zhou M; Yin Y; Tan Y; Chen M; Yin X; Ke G; Zhang XB
    Anal Chem; 2021 Mar; 93(11):4967-4974. PubMed ID: 33703873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets.
    Kadam US; Cho Y; Park TY; Hong JC
    Appl Biol Chem; 2023; 66(1):13. PubMed ID: 36843874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review.
    Habimana JD; Huang R; Muhoza B; Kalisa YN; Han X; Deng W; Li Z
    Biosens Bioelectron; 2022 May; 203():114033. PubMed ID: 35131696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection.
    Huang Z; Liu S; Pei X; Li S; He Y; Tong Y; Liu G
    Biosensors (Basel); 2022 Sep; 12(10):. PubMed ID: 36290917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes - A review.
    Xie S; Ji Z; Suo T; Li B; Zhang X
    Anal Chim Acta; 2021 Nov; 1185():338848. PubMed ID: 34711331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Sensitive and Nonoptical CRISPR Detection Mechanism by Sizing Double-Stranded λ DNA Reporter.
    Mohammad N; Katkam SS; Wei Q
    Angew Chem Int Ed Engl; 2022 Dec; 61(50):e202213920. PubMed ID: 36239984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas-Driven Single Micromotor (Cas-DSM) Enables Direct Detection of Nucleic Acid Biomarkers at the Single-Molecule Level.
    Chen D; Liang Y; Wang H; Wang H; Su F; Zhang P; Wang S; Liu W; Li Z
    Anal Chem; 2023 Apr; 95(13):5729-5737. PubMed ID: 36944919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets.
    Li CY; Zheng B; Liu YH; Gao JL; Zheng MQ; Pang DW; Tang HW
    Biosens Bioelectron; 2020 Dec; 169():112650. PubMed ID: 32987327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas12a-Based Nucleic Acid Amplification-Free DNA Biosensor via Au Nanoparticle-Assisted Metal-Enhanced Fluorescence and Colorimetric Analysis.
    Choi JH; Lim J; Shin M; Paek SH; Choi JW
    Nano Lett; 2021 Jan; 21(1):693-699. PubMed ID: 33346665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards CRISPR powered electrochemical sensing for smart diagnostics.
    Priya Swetha PD; Sonia J; Sapna K; Prasad KS
    Curr Opin Electrochem; 2021 Dec; 30():100829. PubMed ID: 34909513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas system manipulating nanoparticles signal transduction for cancer diagnosis.
    Guo Y; Guo L; Su Y; Xiong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1851. PubMed ID: 36199268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergetic performance of isothermal amplification techniques and lateral flow approach for nucleic acid diagnostics.
    Mukama O; Nie C; Habimana JD; Meng X; Ting Y; Songwe F; Al Farga A; Mugisha S; Rwibasira P; Zhang Y; Zeng L
    Anal Biochem; 2020 Jul; 600():113762. PubMed ID: 32387190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-shaped DNA nanostructures assembled-spherical nucleic acids as target converters to activate CRISPR-Cas12a enabling sensitive ECL biosensing.
    Mei-Ling L; Yi L; Mei-Ling Z; Ying Z; Xiao-Jing H
    Biosens Bioelectron; 2022 Oct; 214():114512. PubMed ID: 35780537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.